RAC 0.96% $1.55 race oncology ltd

@Mason14 (reply not working well) - I am grossly summarising my...

  1. 6,410 Posts.
    lightbulb Created with Sketch. 1612
    @Mason14 (reply not working well) - I am grossly summarising my understanding in simple English of your extensive write up (well supported by scientific data and interpretation) which is way above my comprehension capabilities. Appreciate if you can correct my understanding as I am sure to have missed a lot of what you’re saying but at least I hope to get the conclusion correct even if I couldn’t understand/ appreciate the scientific data.


    Your main point I took away was that other FTO inhibitors despite their FTO inhibition capabilities end up being cardio toxic.

    When Bisantrene is used individually it behaves just like other FTO inhibitors and is cardio toxic, but when used in combo Bisantrene’s special cardio protective properties show up and protects the heart (and its FTO inhibition capabilities either do not cause the same level of cardio toxicity or get suppressed). This unique property of Bisantrene makes it special and invaluable both to patients and shareholders.

    Thanks!
    Last edited by ma420: 30/04/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.015(0.96%)
Mkt cap ! $257.8M
Open High Low Value Volume
$1.59 $1.59 $1.51 $189.1K 121.6K

Buyers (Bids)

No. Vol. Price($)
1 200 $1.52
 

Sellers (Offers)

Price($) Vol. No.
$1.55 999 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
$1.52
  Change
-0.015 ( 2.88 %)
Open High Low Volume
$1.55 $1.58 $1.51 7772
Last updated 15.59pm 17/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.